drugset / Trial / NCT02675309

A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects

NCT02675309

Phase 1 Completed 28 enrolled Tanabe Pharma Corporation
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to investigate the effect of MT-8554 on the pharmacokinetics of simvastatin and rosuvastatin in healthy subjects.

Timeline

Start
2016-02
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Elismetrep Small molecule
Subject Rosuvastatin Small molecule
Subject Simvastatin Small molecule

Indications

No indication recorded.